Novel chalcone compound as well as preparation method, pharmaceutical composition and application thereof
The invention discloses a novel chalcone compound as well as a preparation method, a pharmaceutical composition and application thereof, and belongs to the technical field of medicines, and the chalcone compound (+/-)-Lupulusone A provided by the invention has not been reported at present. Experimen...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a novel chalcone compound as well as a preparation method, a pharmaceutical composition and application thereof, and belongs to the technical field of medicines, and the chalcone compound (+/-)-Lupulusone A provided by the invention has not been reported at present. Experimental results show that the chalcone compound provided by the invention has remarkable anti-inflammatory activity on RAW 264.7 cells induced by lipopolysaccharide, is obviously superior to a positive drug dexamethasone, and can be used for developing drugs for treating various inflammation-related diseases, including but not limited to pneumonia, hepatitis, nephritis, arthritis, conjunctivitis, enterogastritis, metabolic syndrome, diabetes mellitus, cancer and the like.
本发明公开了一种新型查尔酮类化合物及其制备方法、药物组合物和应用,属于医药技术领域,本发明所提供的查尔酮类化合物(±)-Lupulusone A目前尚未见报道。实验结果表明,本发明所提供的查尔酮类化合物对脂多糖诱导的RAW 264.7细胞具有显著的抗炎活性,明显优于阳性药地塞米松,可用于开发治疗各种炎症相关疾病的药物,包括但不限于肺炎、肝炎、肾炎、关节炎、结膜炎、肠胃炎、代谢综合征、糖尿病、癌症等。 |
---|